Full funding of VMX-C001 Phase 3 trial, late-stage product development, manufacturing and pre-launch activities VarmX shareholders to receive initial $117m upfront and further potential milestone ...

Exclusive option agreement for CSL to acquire all issued and outstanding shares of the company, dependent on Phase 3 data LEIDEN, Netherlands, September 16, 2025--(BUSINESS WIRE)--VarmX, a biotech ...

SYDNEY--Australian pharmaceutical company CSL said on Tuesday that it has agreed to a deal to advance a blood coagulation treatment and potentially acquire its closely held Dutch developer. CSL said ...

With the FiAPC® plus probes, Erbe seeks to give physicians greater control over every aspect of the APC application: from energy delivery and beam formation to tip positioning and suction. "Precision ...

DIC related to cancer is always secondary to a well-defined clinical condition. (See Table 1 for a list of common causes of DIC related to cancer.) This point is important to remember, as treatment of ...

The syndrome of disseminated intravascular coagulation (DIC) is a serious hypercoagulation state that occurs in a variety of disease states, including cancer. Although DIC is often associated with ...

Relative depth of invasion (RDI) index and clinicopathologic predictive factors for identifying high axillary nodal burden in ACOSOG Z0011–eligible breast cancer patients. Primary and secondary ...

Coagulation studies help you understand blood disorders, so you can pursue treatment options to improve your blood’s ability to form clots. Blood coagulation, or blood clotting, is a process in which ...

A recent study provides new insights into the mechanisms of coagulation in persons with haemophilia A, the most common form of haemophilia. The research team was able to show that saliva contains ...